Monoclonal antibody
Vapaliximab is a chimeric monoclonal antibody[1] and an experimental immunosuppressive drug.[citation needed] Development was discontinued by 2012.[2]
References
|
---|
Intracellular (initiation) | |
---|
Intracellular (reception) | |
---|
Extracellular | |
---|
Unsorted | |
---|